Clinical trial
Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients…
NCT00486083 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00486083 |
|---|---|
| Title | Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD |
| Official title | A Randomized, Double-Blind Comparison, Safety and Efficacy Trial of Atomoxetine Hydrochloride and Methylphenidate Hydrochloride in Pediatric Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Atomoxetine Hydrochloride, Methylphenidate Hydrochloride |
| Enrollment | 330 |
| Start date | Dec 1, 2003 |
| Completion | Oct 1, 2004 |
| First posted | Jun 13, 2007 |
| Last update posted | Jun 13, 2007 |
| Countries | China, Mexico, South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: